Skip to main content
. 2023 Nov 14;21:437. doi: 10.1186/s12916-023-03122-z

Fig. 4.

Fig. 4

MR association between ADRB1 or ADRB2 and PD risk. ADRB1, β1 adrenergic receptor; ADRB2, β2 adrenergic receptor; CI, confidence interval; MR, Mendelian randomization; OR, odds ratio; PD, Parkinson’s disease